Showing results (371-380 of 381) with videos related to
Sort By:
Pageof 39
Arthritis Care & Research|April 10, 2016
Cost-Effectiveness Analysis of First-Line Treatment With Biologic Agents in Polyarticular Juvenile Idiopathic ArthritisNadia J Luca, Heather F Burnett, Wendy J Ungar, et al.Nature Chemistry|February 12, 2020
Electronic complementarity permits hindered butenolide heterodimerization and discovery of novel cGAS/STING pathway antagonistsBenjamin J Huffman, Shuming Chen, J Luca Schwarz, et al.Organic Letters|November 21, 2019
Accelerated Discovery in Photocatalysis by a Combined Screening Approach Involving MS TagsMichael Teders, Sabrina Bernard, Karin Gottschalk, et al.The Journal of Orthopaedic and Sports Physical Therapy|September 6, 2017
Validation of the Standardized Universal Pain Evaluations for Rheumatology Providers for Children and Youth (SUPER-KIDZ)Nadia J Luca, Jennifer N Stinson, Brian M Feldman, et al.The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|June 20, 2016
The Impact of the Teen Outreach Program on Sexual Intentions and BehaviorsEric R Walsh-Buhi, Stephanie L Marhefka, Wei Wang, et al.JMIR Research Protocols|June 16, 2022
Ensuring a Successful Transition From Cytology to Human Papillomavirus-Based Primary Cervical Cancer Screening in Canada by Investigating the Psychosocial Correlates of Women's Intentions: Protocol for an Observational StudyGabrielle Griffin-Mathieu, Ben Haward, Ovidiu Tatar, et al.Nature|September 11, 2024
Promotion of DNA end resection by BRCA1-BARD1 in homologous recombinationSameer Salunkhe, James M Daley, Hardeep Kaur, et al.Rheumatology and Therapy|July 18, 2021
Evaluation of Real-World Healthcare Resource Utilization and Associated Costs in Children with Juvenile Idiopathic Arthritis: A Canadian Retrospective Cohort StudyLuiza R Grazziotin, Gillian Currie, Marinka Twilt, et al.Science (New York, N.Y.)|May 22, 2025
CTC1-STN1-TEN1 controls DNA break repair pathway choice via DNA end resection blockadeCody M Rogers, Hardeep Kaur, Michelle L Swift, et al.Journal of Clinical Medicine|November 19, 2020
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington's Disease Patients-A Randomized Phase 2 Clinical TrialMichael J Brownstein, Neal G Simon, Jeffrey D Long, et al.Pageof 39